Jsmart Technologies Group Limited Overview
Key identifiers
| Field | Detail | Source |
|---|---|---|
| Legal name | Jsmart Technologies Group Limited | AR 2025-26 |
| Chinese secondary name | 金安具身智能科技集團有限公司 (stock short name 金安智能) | AR 2025-26 |
| Former names | Daisho Microline Holdings Limited (大昌微綫集團有限公司) | AR 2025-26; HKEX notice 23 Jun 2026 |
| Founding / listing | Listed on the HKEX Main Board on 31 January 1990. Aggregators give 1990 as the incorporation year. | irasia.com profile; Finnomena |
| Incorporation jurisdiction | Bermuda (exempted company with limited liability) | AR 2025-26 |
| Registered office | Victoria Place, 5th Floor, 31 Victoria Street, Hamilton HM 10, Bermuda | AR 2025-26 |
| Head office / principal place of business | Suite 22C, 22/F, 228 Electric Road, North Point, Hong Kong (from 15 May 2026). Previously Unit A, 10/F, Fook Hing Industrial Building, 33 Lee Chung Street, Chai Wan. | AR 2025-26; Morningstar |
| Exchange / ticker | Stock Exchange of Hong Kong, Main Board; 0567 (00567.HK) | HKEX |
| ISIN | BMG2624V1063 | MarketsMojo; user list |
| CUSIP | Not publicly disclosed (not applicable to a HKEX-only listing) | — |
| Fiscal year end | 31 March | AR 2025-26 |
| Employees | 204 at 31 Mar 2026; 226 at 31 Mar 2025. For historical scale: 1,505 at 31 Mar 2007 and 2,001 at 31 Mar 2006. | AR 2025-26; AR 2007 |
| Auditor | Prism Hong Kong Limited (Registered Public Interest Entity Auditor) | AR 2025-26 |
| Legal advisers | Michael Li & Co. (Hong Kong law); Appleby (Bermuda law) | AR 2025-26 |
| Share registrars | Principal: Appleby Global Corporate Services (Bermuda) Ltd. Hong Kong branch: Tricor Investor Services Ltd. | AR 2025-26 |
| Shares in issue | 1,613,287,570 ordinary shares of HK$0.10 each. Authorised capital is HK$400 million (4 billion shares). | AR 2025-26; August 2026 monthly return |
| Market capitalisation | About HKD 419.5 million at HK$0.260 per share (16 July 2026 quote). Implied check: 1,613.29M shares × 0.26 = 419.5M. A live October 2026 price was not verifiable. | Investing.com |
| Website | www.jsmartech.hk (formerly www.irasia.com/listco/hk/daisho) | AR 2025-26 |
| Principal bankers | Bank of China; Bank of Communications; China Merchants Bank; Chiyu Banking; Nanyang Commercial Bank; OCBC Bank (HK); CMB Wing Lung Bank | AR 2025-26 |
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Employees at year end (number) | — | 226 | 204 |
| Total staff costs incl. directors (HKD M) | — | 24.5 | 21.9 |
Jsmart Technologies Group is a Hong Kong-headquartered, Bermuda-incorporated micro-cap in the middle of an attempted reinvention.
Its operating base is two small legacy manufacturing businesses in Guangdong:
-
printing and packaging, made in Shenzhen;
-
printed circuit boards (PCBs), made in Huizhou.
Together they generated only HK$43.4 million of revenue in FY2026, down from HK$106.5 million in FY2022. The group has been loss-making in each of the last five years.
In April 2026 control of the largest stake changed hands. Jsmart Technologies Limited, founded in 2024 by former CITIC Capital and Value Partners private-equity executive Dr. Sun Jingan, bought the 17.36% block. The company was then renamed around an "embodied intelligence" (AI plus robotics) strategy.
The new vision so far rests on two things:
-
a 15.12% associate stake in a Beijing AI-health-management platform;
-
a newly formed robotics joint subsidiary targeting healthcare, rehabilitation and elderly care.
The equity is therefore best viewed as an early-stage, thinly capitalised transformation option, not as an established robotics operator.
Data discrepancy flag
Investing.com describes the company as "a subsidiary of Kingboard Holdings Limited". This is not supported by the FY2026 annual report. Its register of substantial shareholders lists:
-
Spring Global / Ng Man Chan / Li Mi Lai (26.41% aggregate at 31 March 2026);
-
Apact Consultancy (6.44%).
Kingboard is not listed, and no Kingboard holding of 5% or more appears. The aggregator statement should be treated as erroneous or stale. Investing.com's descriptor of the company as an intelligent-robotics R&D and manufacturing business also overstates current operations. The disclosed revenue is entirely from PCB and printing.
Company's own description (Annual Report 2025-2026, Report of the Directors)
The company's principal activity is investment holding. It operates through four reporting segments:
-
PCB: manufacturing and trading of printed circuit boards.
-
Printing Business: manufacturing and trading of printing and packaging products.
-
Trading of petroleum and energy products and related business: dormant, with no revenue since 2019.
-
Investments holding.
The Chairman's Statement adds a narrative "Smart Healthcare Business Segment". This covers the associate investment in Beijing Weihang Yining and the April 2026 AI-robotics joint subsidiary. As of FY2026, this "segment" generated no consolidated revenue. The associate is equity-accounted.
The Chairman frames the strategy as "strategic expansion into AI and robotics industries" to diversify revenue streams. He describes these as high-growth markets the group could not previously reach.
Independent characterisation
In economic substance, Jsmart today is three things:
-
A sub-scale contract manufacturer of printed and packaging products. It is customer-concentrated: the top customer accounts for 31% of group sales and the top five for 73% (FY2026). It is exposed to export-oriented consumer demand that customers are diversifying away from China.
-
A very small PCB maker. Revenue was about HK$15.7 million in FY2026. Its boards go into:
-
smart residential buildings;
-
commercial-building central control systems;
-
consumer electronics;
-
(by management's description) cloud computing. It has no disclosed scale or technology advantage. Peers produce boards on volumes several orders of magnitude larger.
-
-
A listed shell-like platform with a small investment book. This includes:
-
the equity-accounted 15.12% stake in Beijing Weihang Yining, carried at HK$29.8 million, or 32.7% of total assets;
-
a 40% joint-venture interest in Noricap Fund G.P. Limited, which holds an indirect 0.86% interest in an SFC-licensed cryptocurrency automated-trading-platform operator;
-
a newly formed robotics subsidiary.
-
Business and revenue model
| Dimension | Characterisation | Evidence |
|---|---|---|
| Product vs service | 100% of FY2026 consolidated revenue is from manufactured products: 63.8% printing/packaging and 36.2% PCB (derived) | AR 2025-26 MD&A |
| Subscription / licensing | None disclosed | AR 2025-26 |
| Revenue recognition | Product sales under HKFRS 15, mainly at a point in time | FY2023/FY2024 results announcements |
| Value chain position | Mid-stream converter. Buys paper, inks, copper-clad laminate and chemicals; sells to OEMs and brand owners. | AR 2025-26 ESG climate table |
| Customer types | B2B: brand owners and packaging buyers; electronics OEMs (building automation, consumer electronics) | AR 2025-26 |
| End-markets | Consumer goods packaging; smart buildings; consumer electronics; cloud/data infrastructure (claimed); NEV and embodied-AI (aspirational) | AR 2025-26 Chairman's Statement |
| Customer concentration | Largest customer 31%; top five 73% | AR 2025-26 |
| Supplier concentration | Largest supplier 14%; top five 35% | AR 2025-26 |
| Currency exposure | RMB, HKD and USD. No hedging derivatives in FY2026. | AR 2025-26 |
Planned new model (aspirational)
Management's stated intent is to:
-
commercialise AI and intelligent robots in medical treatment, rehabilitation and elderly care, through the joint subsidiary formed on 7 April 2026;
-
"advance the application of technologies in the embodied intelligence sector" from the PCB base.
No revenue model, pricing, product specification, capital budget or timeline for these initiatives has been disclosed. The annual report states the group has no concrete plans for material investments or capital assets acquisitions for the coming 12 months. This sits awkwardly with the rebranding narrative.
Strategy
Stated strategic themes (paraphrased from AR 2025-26 Chairman's Statement and MD&A)
-
Strategic expansion into AI and robotics ("embodied intelligence"). The aim is to diversify revenue streams and access high-growth markets the group could not previously reach. The name change is presented as aligning the corporate brand with this direction.
-
Prudent management of legacy businesses. This includes cost control, supplier management, inventory optimisation, product-mix improvement and customer-base expansion in printing.
-
Leveraging PCB capability for new demand. Targets are digital innovation, new energy vehicles and the embodied-intelligence sector.
-
Smart healthcare. AI health management (Weihang Yining) and robotics for medical treatment, rehabilitation and elderly care (the April 2026 JV).
-
Investment diversification. The Noricap Fund vehicle provides fund and financial-technology exposure.
Initiatives in the last 24 months
| Date | Initiative | Type | Disclosed targets |
|---|---|---|---|
| 28 Mar 2025 | RMB28.5M capital injection for 15.12% of Weihang Yining | Strategic investment (AI health) | — |
| 30 Jun 2025 | Noricap JV partner changed from LBG to HKFA Clearing | Investment vehicle restructuring | — |
| FY2026 | Noricap completed an HK$18.1M investment for an indirect 0.86% of a crypto trading-platform operator | Financial investment | — |
| 7 Apr 2026 | Joint subsidiary with Weihang Yining and Beijing Jsmart Embodied Intelligent System for AI and robots in healthcare and elderly care | New business launch | None disclosed |
| 20 Apr 2026 | Board reshaped: Dr. Sun appointed ED | Leadership | — |
| Apr–Jun 2026 | Name change, new website, HQ move | Rebranding | — |
| FY2026 | ESG targets: 3%/10%/15% intensity reductions vs 2025 baseline (energy, waste, GHG Scope 1+2, water) over short, medium and long term | Sustainability | See Section 20 |
Medium-term financial targets / guidance
None disclosed.
-
The company provides no revenue, margin or profitability guidance.
-
It states it has no concrete plans for material investments or capital asset acquisitions over the coming 12 months.
-
No investor day, earnings call or presentation has been identified.
Products & Services
The company discloses very little product-level detail. Each item below reflects the maximum verifiable granularity.
Printing & Packaging (Shenzhen)
| Item | Description | Target customer | Launch / version | Pricing | Flagship |
|---|---|---|---|---|---|
| Printed and packaging products | Custom printing and packaging made to client specification, with emphasis on "high-quality" output | Brand owners and consumer-product companies; customers concentrated (top five = 73% of group sales) | Long-standing; launch year not disclosed | Order-based; not disclosed | — |
| Process notes | Uses inks (hazardous waste: waste ink cans 0.09 t in FY2026) and drying processes; packaging-material consumption cut 31% vs FY2025 | — | — | — | — |
Printed Circuit Boards (Huizhou)
| Item | Description | Target customer | Launch / version | Pricing | Flagship |
|---|---|---|---|---|---|
| PCBs for smart residential buildings | Control-board applications in smart-home and building systems | Building-automation OEMs | — | — | — |
| PCBs for commercial-building central control systems | Boards for HVAC, BMS and central control | Commercial building-systems OEMs | — | — | — |
| PCBs for consumer electronics | General consumer-electronics boards | Consumer-electronics OEMs | — | — | — |
| PCBs for automotive / cloud computing | Earlier profiles cite automotive; AR 2025-26 cites cloud computing | Auto and cloud-hardware OEMs | — | — | — |
Technical specifications: layer count, HDI capability, materials and certifications are not publicly disclosed. Management notes the technical and quality-control teams have "over two decades" of industry experience.
Investments & New Initiatives
| Item | Description | Status |
|---|---|---|
| Beijing Weihang Yining Health Management Group (15.12% associate) | Operates an AI medical system with a health-management platform integrating high-end medical resources | Completed in FY2026; carrying value HK$29.8M; share of loss HK$0.7M |
| AI and intelligent-robotics joint subsidiary (formed 7 Apr 2026) | Commercial application and development of AI and robots in medical treatment, rehabilitation and elderly care | Newly formed. Name, ownership split, capital and products not disclosed. |
| Noricap Fund G.P. (40% JV) | Special-purpose fund vehicle; holds an indirect 0.86% stake in an SFC-licensed crypto automated-trading-platform provider (cost about HK$18.1M) | Completed |
| Petroleum and energy trading | Dormant since 2019 | Management "actively seeking" resumption (irasia profile, 2023) |
No robotics product has been named, specified, priced or launched by the listed group as of the research date.
Financial Narrative
Source: AR 2025-26 five-year summary unless noted. Currency HKD. Fiscal years end 31 March.
Income statement
Notes on the income statement
-
Gross profit for FY2024 and FY2025 is from the profit warning (about HK$17.7M and HK$10.2M). FY2026 is from the results announcement.
-
Administrative expenses come from the FY2023 results announcement.
-
Loss before tax is identical (HK$21.285M) in FY2025 and FY2026 per the five-year summary; the difference is in tax.
Per-share data (HK cents)
Notes: FY2023, FY2024 and FY2026 EPS are as reported (Moomoo/PUBT). FY2022 and FY2025 are derived from the net loss divided by 1,613,287,570 shares. Diluted equals basic because no options are outstanding. No dividends were declared in any year shown.
Margins (%, derived)
Notes: Gross margin for FY2025 and FY2026 is as reported (19.3% and 21.9%). FY2022 margins use continuing revenue. Operating and EBITDA margins are not computable.
Revenue CAGR, FY2022–FY2026 (continuing): (43,426 / 106,471)^(1/4) − 1 = −20.1% per year.
Balance sheet
Notes on the balance sheet
-
Total assets and total liabilities are derived as sums.
-
Cash: FY2026 is HK$3.23M per PUBT; borrowings are about HK$3.2M (2025: nil). Net debt for FY2026 is approximately zero.
-
The short-term vs long-term split of debt is not publicly disclosed in retrieved extracts. The rise in non-current liabilities suggests part may be long-term or lease-related.
-
Goodwill and intangibles are not disclosed and are presumed immaterial.
Cash flow
AR 2025-26 states that no securities were repurchased in FY2026, and there were no capital commitments at year end.
Commentary on trends, inflections and drivers
1. Structural revenue decline.
-
Continuing revenue fell from HK$106.5M (FY2022) to HK$43.4M (FY2026), a −20.1% CAGR.
-
The only up-year was FY2024 (+2.2%), driven by an 11.5% printing rebound.
-
The FY2025 collapse (−38.0%) was led by a HK$25.2M fall in printing revenue. The profit warning attributes this to customers turning cautious amid global trade tensions. Management repeatedly says customers are "sourcing from different countries to diversify risk", which is a classic China+1 headwind for a Shenzhen converter.
2. Gross margin is resilient but too small to matter.
-
Gross margin held around 19–22% and improved to 21.9% in FY2026 on lower staff costs.
-
But absolute gross profit (HK$9.5M) is far below the cost base. Staff costs alone were HK$21.9M, and administrative expenses historically ran at HK$27–31M.
-
The business is therefore structurally loss-making at current scale.
3. Persistent losses erode equity.
-
Cumulative net losses over FY2022–FY2026 total about HK$109.4M.
-
Equity fell 62% from HK$132.7M to HK$49.8M. Equity per share is about HK$0.031.
4. FY2026 liquidity inflection.
-
Cash fell from HK$19.9M to HK$3.2M (−HK$16.7M), mainly because the RMB28.5M (about HK$30.5M) Weihang Yining capital injection completed during the year.
-
The group took on HK$3.2M of borrowings, and the current ratio dropped from 1.80x to 1.19x.
-
Net current assets of HK$7.3M equal roughly four months of the FY2026 net-loss run-rate. This makes near-term capital raising highly probable absent a turnaround or asset monetisation. This is analyst inference, not company guidance.
5. Balance-sheet composition shift.
-
One illiquid, equity-accounted minority stake (HK$29.8M) now represents 32.7% of total assets.
-
Recoverability of this stake is a key audit and valuation judgment. No impairment was recognised in FY2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Operating base | Status |
|---|---|---|---|
Manufacturing and trading of printing and packaging products ("Printing Business") | Printed products and packaging made to customer specification | Shenzhen factories, over 125,000 sq ft | Active; largest revenue contributor |
Manufacturing and trading of PCB | Printed circuit boards for smart buildings, central control systems, consumer electronics, cloud computing and automotive | Huizhou factories | Active |
Trading of petroleum and energy products and related business | Commodity and energy trading | — | Suspended since 2019; no revenue |
Investments holding | Noricap Fund JV (40%); other investments | Hong Kong | No revenue |
"Smart Healthcare" (narrative only) | 15.12% associate in Weihang Yining; April 2026 AI-robotics joint subsidiary | Beijing | Not a separately reported revenue segment in FY2026 |
Revenue by Segment
| Segment | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Printing and packaging revenue (HKD K) | 70,817 | 52,957 | 59,036 | 33,790 | 27,700 |
PCB revenue derived (HKD K) | 35,654 | 30,801 | 26,548 | 19,307 | 15,726 |
Petroleum and energy trading revenue (HKD K) | 0 | 0 | 0 | 0 | 0 |
Total continuing revenue (HKD K) | 106,471 | 83,758 | 85,584 | 53,097 | 43,426 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Printing revenue YoY growth (%) | -25.2 | 11.5 | -42.8 | -18.0 |
PCB revenue YoY growth derived (%) | -13.6 | -13.8 | -27.3 | -18.5 |
Printing share of total revenue (%) | 63.2 | 69.0 | 63.6 | 63.8 |
PCB share of total revenue (%) | 36.8 | 31.0 | 36.4 | 36.2 |
Results by Segment
| Segment result | FY2025 | FY2026 |
|---|---|---|
Printing Business segment result (HKD Mn) | -11.0 | -12.6 |
PCB segment result (HKD Mn) | -1.2 | -1.6 |
Petroleum trading segment result (HKD Mn) | 0 | 0 |
Segment Margins & Growth (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Printing segment margin derived (%) | -32.6 | -45.5 |
PCB segment margin derived (%) | -6.2 | -10.2 |
Income Statement
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue continuing (HKD K) | 106,471 | 83,758 | 85,584 | 53,097 | 43,426 |
Revenue incl discontinued (HKD K) | 109,238 | 83,758 | 85,584 | 53,097 | 43,426 |
Gross profit (HKD K) | — | — | 17,700 | 10,200 | 9,530 |
Loss before tax (HKD K) | -29,149 | -25,868 | -11,873 | -21,285 | -21,285 |
Income tax credit or expense (HKD K) | 21 | -149 | 0 | 159 | 14 |
Net loss attributable to owners (HKD K) | -29,128 | -26,017 | -11,873 | -21,126 | -21,271 |
Administrative expenses (HKD K) | -31,157 | -26,754 | — | — | — |
Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Basic EPS (HK cents) | -1.81 | -1.61 | -0.74 | -1.31 | -1.32 |
Diluted EPS (HK cents) | -1.81 | -1.61 | -0.74 | -1.31 | -1.32 |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | — | — | 20.7 | 19.3 | 21.9 |
Pre-tax margin (%) | -27.4 | -30.9 | -13.9 | -40.1 | -49.0 |
Net margin (%) | -27.4 | -31.1 | -13.9 | -39.8 | -49.0 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Non-current assets (HKD K) | 50,543 | 49,930 | 46,896 | 48,409 | 44,991 |
Current assets (HKD K) | 125,065 | 94,673 | 78,213 | 56,505 | 46,107 |
Total assets (HKD K) | 175,608 | 144,603 | 125,109 | 104,914 | 91,098 |
Current liabilities (HKD K) | 42,801 | 38,376 | 31,282 | 31,395 | 38,792 |
Non-current liabilities (HKD K) | 146 | 313 | 14 | 1,000 | 2,529 |
Total liabilities (HKD K) | 42,947 | 38,689 | 31,296 | 32,395 | 41,321 |
Total equity (HKD K) | 132,661 | 105,914 | 93,813 | 72,519 | 49,777 |
Net current assets working capital (HKD K) | 82,264 | 56,297 | 46,931 | 25,110 | 7,315 |
Cash and bank balances (HKD K) | — | — | — | 19,900 | 3,200 |
Interest-bearing borrowings (HKD K) | — | — | — | 0 | 3,200 |
Net debt (HKD K) | — | — | — | -19,900 | 0 |
Investment in associate Weihang Yining (HKD K) | — | — | — | — | 29,800 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividends paid (HKD K) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD K) | 0 | 0 | 0 | 0 | 0 |
Net change in cash and bank balances (HKD K) | — | — | — | — | -16,700 |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
ROE on average equity (%) | -21.8 | -11.9 | -25.4 | -34.8 |
ROA on average assets (%) | -16.3 | -8.8 | -18.4 | -21.7 |
Current ratio (x) | 2.47 | 2.50 | 1.80 | 1.19 |
Debt to equity excl leases (%) | — | — | 0.0 | 6.4 |
Gearing per company (%) | — | — | 2.8 | 8.6 |
Asset turnover (x) | 0.52 | 0.63 | 0.46 | 0.44 |
Capital Markets
| Item | Value | Source / date |
|---|---|---|
Last verified price | HK$0.260 | Investing.com, 16 Jul 2026 (previous close HK$0.295) |
Earlier reference price | HK$0.089 (market cap about HK$143.6M) | Simply Wall St screen; date not specified, pre-2026 |
Other reference | HK$0.29, shown with +192% change (period ambiguous) | MarketsMojo |
3-year trend | Share price up about 23% per year over three years while EPS fell about 9% per year | Simply Wall St |
1-year and 5-year returns | Not verifiable precisely | — |
Market cap | About HK$419.5M at HK$0.26 | Derived |
Trailing EPS | −HK$0.013 | Investing.com; Simply Wall St |
Valuation Snapshot
| Multiple | Value | Calculation |
|---|---|---|
P/E | Not meaningful (loss-making) | — |
P/B | About 8.4x | HK$419.5M ÷ HK$49.8M equity |
EV/Sales | About 9.7x | EV ≈ market cap + debt − cash ≈ HK$419.5M; ÷ FY2026 revenue HK$43.4M |
EV/EBITDA | Not meaningful | EBITDA undisclosed and likely negative |
Capital Markets — Analyst consensus
| Item | Status |
|---|---|
Analyst consensus | No sell-side coverage identified |
Dividend history and policy | No dividends FY2022–FY2026. No distributable reserves under the Bermuda Companies Act at 31 Mar 2025 or 31 Mar 2026. |
Buybacks | None in FY2026; no treasury shares; no authorisation beyond the general mandate disclosed |
Credit ratings (Moody's / S&P / Fitch) | None; unrated |
Debt maturity profile | About HK$3.2M of interest-bearing borrowings; maturity split not disclosed |
Share capital | 1,613,287,570 shares; authorised 4bn at HK$0.10 par. Unchanged through Aug 2026. |
Option overhang | 0 options outstanding; mandate capacity 161,328,757; scheme expiring around Nov 2026 |
Share Count (millions) and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Shares in issue (millions) | 1,613.29 | 1,613.29 | 1,613.29 | 1,613.29 | 1,613.29 |
Book value per share (HK cents) | 8.22 | 6.57 | 5.82 | 4.50 | 3.09 |
Analyst Conclusions
Management guidance
No quantitative guidance is given. Qualitatively:
-
the printing segment is expected to remain under sales pressure;
-
PCB demand remains pressured, with hoped-for relief from digital innovation and NEV demand;
-
the group will "undergo strategic expansion into AI and robotics" while running legacy businesses prudently.
Consensus expectations
No analyst consensus exists.
Bull case
-
Platform re-rating with asset injection. The new 17.36% holder controls an embodied-AI venture that shares the group's new name. Injecting real robotics revenue into a listed vehicle with a clean float could transform the investment case, and the market already prices this at about 8x book.
-
Healthcare-robotics channel. The JV pairs Weihang Yining's health-management network (15.12% associate, HK$29.8M carrying value) with robotics capability. It targets China's ageing-population demand within a smart-robots market growing about 21% a year (TBRC).
-
Low leverage, small cost base. Gearing is 8.6% and headcount fell to 204. That leaves room to raise equity or debt and pivot without legacy obligations. Historical litigation is resolved.
Bear case
-
Funding cliff. Cash is HK$3.2M and net current assets HK$7.3M against an annual loss of about HK$21M. A dilutive raise or asset sale appears unavoidable within roughly 12 months.
-
Narrative ahead of substance. There is no disclosed robotics product, R&D spend, IP or revenue. Management itself says it has no concrete material-investment plan for the next 12 months.
-
Legacy erosion is structural. Revenue has fallen at a −20% CAGR since FY2022. Printing customers are relocating sourcing, and 73% of sales come from five customers, so further losses could be abrupt.
Catalysts and monitorables (next 12 months)
Interim results: for the six months to 30 Sep 2026, expected around November 2026. Watch cash, borrowings, the first consolidation of the robotics JV, and any going-concern language.
-
Any placing, rights issue or convertible issuance, including size, price and subscriber identity.
-
Announcements of asset injection or acquisition from Jsmart-related entities, and HKEX RTO treatment.
Disclosure of the robotics JV: shareholding, capital, first products or contracts.
Weihang Yining: performance and impairment testing.
Noricap/crypto stake: valuation or exit.
2026 AGM poll results: and any further board changes (e.g., a CEO appointment).
- Expiry or renewal of the share option scheme around November 2026, which could be used to incentivise a robotics team.
Customer losses: in printing; PCB order trends.
Analyst verdict
Jsmart Technologies Group is, at present, a rebranding without yet being a robotics company.
The listed entity's operating reality is two sub-scale Guangdong manufacturing businesses. Their combined revenue has fallen from HK$106.5 million to HK$43.4 million in four years, and they lose about HK$21 million a year. The FY2026 balance sheet shows the strain clearly:
-
cash fell to HK$3.2 million;
-
the current ratio fell to 1.19x;
-
one-third of total assets is now tied up in an equity-accounted, illiquid minority stake in a Beijing health-management platform.
Nothing in the filings shows proprietary robotics technology, R&D spending, patents or customer contracts at the listed-group level.
The strategic logic of the April 2026 change of the substantial shareholder is nevertheless clear. Dr. Sun Jingan brings serious capital-markets pedigree from CITIC Capital and Value Partners PE, and he controls an embodied-AI venture named for the new listed vehicle. A clean Main Board platform with 25% public float, minimal debt and resolved legacy litigation is an efficient vehicle to house and finance robotics assets. The joint subsidiary with Weihang Yining in healthcare, rehabilitation and elderly-care robotics points to the intended direction.
The equity's valuation, roughly 8x book and nearly 10x sales at HK$0.26, already discounts a meaningful part of that optionality. The near-term path almost certainly runs through dilution: either a cash raise or an asset injection paid in shares. Minority holders' outcomes will depend on the pricing and independence of those transactions, and on HKEX treatment of any reverse-takeover-like restructuring.
Verdict: a speculative special situation, not an investable operating story. Monitor the November 2026 interim results, any capital-raising terms, and connected-transaction disclosures as the decisive evidence. Absent concrete asset injection, the fundamentals point to continued equity erosion.
APPENDIX: SOURCE LIST
-
Jsmart Technologies Group, Annual Report 2025-2026: https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0723/2026072301180.pdf
-
Daisho Microline, Annual Report 2024-2025: https://www.hkexnews.hk/listedco/listconews/sehk/2025/0724/2025072400682.pdf
-
Profit warning, 19 Jun 2025 (English): https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0619/2025061900920.pdf
-
Profit warning, 19 Jun 2025 (Chinese): https://www.hkexnews.hk/listedco/listconews/sehk/2025/0619/2025061900921_c.pdf
-
FY2024 annual results announcement: https://www1.hkexnews.hk/listedco/listconews/sehk/2024/0625/2024062501405.pdf
-
FY2023 annual results announcement: https://www1.hkexnews.hk/listedco/listconews/sehk/2023/0627/2023062701634.pdf
-
Annual Report 2022-2023: https://www1.hkexnews.hk/listedco/listconews/sehk/2023/0721/2023072100338.pdf
-
Annual Report 2021-2022: https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0726/2022072600365.pdf
-
Annual Report 2007: https://www.hkexnews.hk/listedco/listconews/sehk/2007/0727/00567_192086/E105.pdf
-
Interim Report 2005: https://www.hkexnews.hk/listedco/listconews/sehk/2005/1229/00567/EWF119.pdf
-
Registrar change announcement, 2 Aug 2022: https://www1.hkexnews.hk/listedco/listconews/sehk/2022/0802/2022080202395.pdf
-
HKEX trading notice on the name change: https://www.hkexnews.hk/eng/market/sec_tradinfo/tradarng/tradarng_news/premonth/e567a_260623.htm
-
SGM notice summary (Tiger Brokers): https://www.itiger.com/news/1106775624
-
SGM poll results summary (minichart): https://www.minichart.com.sg/2026/05/22/daisho-microline-holdings-limited-passes-special-resolution-to-change-company-name-at-may-2026-sgm/
-
FY2026 results brief (Webull/PUBT): https://www.webull.hk/en/news/15078998757508096
-
SGM brief (Webull/PUBT): https://www.webull.hk/en/news/14834044850881536
-
Investing.com quote page: https://in.investing.com/equities/daisho-microline
-
Simply Wall St dividend page: https://simplywall.st/ja/stocks/hk/tech/hkg-567/jsmart-technologies-group-shares/dividend
-
MarketsMojo financials: https://www.marketsmojo.com/stocks-analysis/financial-annual/daisho-microline-holdings-1108977-102
-
Morningstar profile: https://www.morningstar.com.au/investments/security/HKSE/00567
-
Zonebourse company page: https://www.zonebourse.com/cours/action/JSMART-TECHNOLOGIES-GROUP-1412805/societe/
-
irasia.com company profile: https://irasia.com/listco/hk/daisho/profile.htm
-
etnet announcement list: https://www.etnet.com.hk/mobile/tc/stocks/quote_announcement.php?code=567
-
Caiwen news (August 2026 monthly return): https://www.caiwennews.com/article/1578831.shtml
-
Smart robots market (TBRC via GII): https://www.gii.co.jp/report/tbrc1924203-smart-robots-global-market-report.html
-
Robotics & smart machines market (TBRC via GII): https://www.gii.co.jp/report/tbrc2066338-robotics-smart-machines-global-market-report.html
-
Smart robots market (Grand View Research via DRI): https://www.dri.co.jp/auto/report/grandview/241106-smart-robots-market-size-share-trends.html
-
JARA forecast (MReport): https://www2024.mreport.co.th/en/tag/news/หุ่นยนต์อุตสาหกรรม
-
Doosan Robotics / Nvidia (Korea Herald): https://www.koreaherald.com/article/10762448
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Age | Background | Education |
|---|---|---|---|---|---|
Lee Man Kwong | Chairman; Executive Director; Chair of Nomination Committee; Remuneration Committee member | INED 14 Dec 2016 → NED 1 Mar 2017 → ED 1 Jun 2018 → Chairman 16 Oct 2020 | 71 | Senior partner, Chan, Lau & Wai, Solicitors. Former directorships at CCT Fortis, Neo Telemedia (chairman), Sau San Tong, Mei Ah Entertainment, Uni-Bio Science, Asia Standard Hotel. | Solicitor (Hong Kong 1983; England & Wales; Singapore) |
Dr. Sun Jingan | Executive Director; Authorised Representative | 20 Apr 2026 | 52 | Founder and director of Jsmart Technologies Limited (2024); robotics and embodied-AI commercialisation. Formerly director and GM of CITIC Capital (Qingdao) Investment Mgmt; director and GM of Value Partners Private Equity Fund; investment director at China Shipping Fund; VP at CITIC Capital Holdings; manager at China CITIC Bank and CITIC Bank International (1999–2021). | BA Investment Economics, Shandong Univ. of Finance & Economics (1996); MA and PhD Finance, Renmin University (1999, 2006); CFA |
Yau Pak Yue | Non-executive Director; Audit Committee member | 3 Sep 2020 | 57 | Former Big Four partner (2005–2012); former Chief Knowledge Officer of Guangzhou Chengfa Capital; director of Ewin Advisory. Multiple HK-listed INED roles (442, 309, 1636). | B.Com (Accountancy), University of Wollongong; HKICPA; FCPA (Aus) |
Dr. Chan Yau Ching, Bob | INED; member of all three committees | 3 Sep 2018 | 63 | MD of KBR Capital and KBR Fund Management; INED of Lee's Pharmaceutical (950) since 2002; former ED of Celestial Asia Securities; former CEO of Moli Group | BBA CUHK (1984); MBA Wisconsin-Madison (1986); PhD Finance, Purdue (1994) |
Dr. Leung Hoi Ming | INED; member of all three committees | 30 Apr 2021 | 58 | Former SVP, Treasury & Markets, DBS Bank; Citibank quant analyst (1996); INED of Yuan Heng Gas (332) | BSc CUHK (1990); MSc and PhD Mathematics, Caltech (1993, 1996); MSc Investment Mgmt, HKUST (1999) |
Lin Ying | INED; Chair of Audit and Remuneration Committees; Nomination Committee member | 20 Sep 2024 | 50 | Director of Shandong Rio Culture & Technology; former Deloitte FAS, PwC, Arthur Andersen; INED of 442 and 332 | BEcon (Taxation), Guangdong Univ. of Finance & Economics (1998); CICPA |
Wong Siu Hung, Patrick | Former NED (previously ED) | Resigned 20 Apr 2026 | — | — | — |
Executive Leadership Team
| Name | Role | Age | Joined | Background |
|---|---|---|---|---|
Ou Zhong | CEO of a major PRC subsidiary | 50 | Jun 2017 | 23+ years in electronics operations, R&D and market development; ex-state-owned enterprises; BEng Automation, Guangdong University of Technology |
Ye Xian Bang | Production Manager of a major PRC subsidiary | 55 | Sep 2013 | 13+ years in printing and packaging; Huizhou University graduate |
Ng Yu Ho | Company Secretary (per AR 2025-26) | — | — | The August 2026 monthly return was signed by 陳駿軒 as company secretary, implying a change after July 2026. |
Governance Overview
| Attribute | Status |
|---|---|
Board size | 6 (2 ED, 1 NED, 3 INED) |
Independence | 50% INEDs, which meets the HKEX one-third minimum |
Chair/CEO separation | No group CEO is named. The Chairman is an executive director, so the roles are effectively combined at board level. |
Committees | Audit (chaired by an INED; 3 INEDs plus 1 NED); Remuneration (chaired by an INED); Nomination (chaired by the Chairman) |
Gender diversity | 1 of 6 directors female (Ms. Lin Ying) |
Director share ownership | Lee Man Kwong holds 10,000 shares (0.0006%). Dr. Sun is deemed interested in 280,000,000 shares (17.36%) via Jsmart Technologies Limited, which is co-owned with his spouse Ms. Ma Ying (post-April 2026). |
Overboarding flags | Several directors hold multiple HK-listed directorships (e.g., Yau: 3 current INED roles plus a history of 10+ boards) |
Major Shareholders
| Holder | Shares | % | Note |
|---|---|---|---|
Spring Global Enterprises Ltd (100% Ng Man Chan) | 280,000,000 | 17.36 | Sold to Jsmart Technologies Ltd on 7 Apr 2026 |
Ng Man Chan (direct, via Spring Global, and jointly) | 426,028,000 | 26.41 | 120,068,000 direct + 280,000,000 Spring Global + 25,960,000 joint with spouse |
Li Mi Lai (spouse) | 426,028,000 (deemed) | 26.41 | Same interest |
Apact Consultancy (Hong Kong) Co. Ltd (investment manager) | 103,826,000 | 6.44 | — |
Major Shareholders — Jsmart Technologies Limited
| Holder | Shares | % |
|---|---|---|
Jsmart Technologies Limited (Dr. Sun Jingan and Ms. Ma Ying) | 280,000,000 | 17.36 |
Ng Man Chan (direct) | 120,068,000 | 7.44 |
Ng Man Chan and Li Mi Lai (joint) | 25,960,000 | 1.61 |
Apact Consultancy (Hong Kong) | 103,826,000 | 6.44 |
Public float | ≥25% confirmed | — |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Listing | Relative positioning vs Jsmart |
|---|---|---|---|
PCB | Kingboard Holdings | HKEX: 0148 | Vertically integrated laminate-to-PCB giant; orders of magnitude larger |
PCB | Kingboard Laminates | HKEX: 1888 | Upstream laminate supplier/competitor; vastly larger |
PCB | Shennan Circuits | SZSE: 002916 | High-end communications/server PCB leader |
PCB | Victory Giant Technology | SZSE: 300476 | AI-server and high-layer-count boards; much larger |
PCB | Meiko Electronics | TSE: 6787 | Japanese automotive and data-centre board maker |
PCB | Elec & Eltek | SGX | HK-rooted PCB maker; larger scale |
Printing & packaging | Hung Hing Printing Group | HKEX: 0450 | Established HK printing and packaging group; larger |
Printing & packaging | Numerous unlisted Pearl River Delta converters | — | Fragmented price competition |
AI robotics (aspirational) | UBTech Robotics | HKEX: 9880 | Listed humanoid/service-robot leader |
AI robotics (aspirational) | Dobot | HKEX: 2432 | Collaborative-robot specialist |
AI robotics (aspirational) | Doosan Robotics | KRX | Cobot maker developing an agentic robot OS with Nvidia (Korea Herald, 2026) |
Healthcare/elderly-care robotics | Fourier Intelligence and other rehab-robot specialists | Unlisted | Domain-specific incumbents |
Competitor Detail
| Metric | Jsmart FY2026 |
|---|---|
Revenue | HK$43.4M |
Revenue growth | −18.3% |
Gross margin | 21.9% |
Net margin | −49.0% |



